EcoDrugPlus

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSOTSG00005047686
Gene Symbol: TUBB4B
1 Cross references
36 Possible Orthologues:

Tubulin, Alpha 7 Like

Ensembl ID : ENSOTSG00005016681
Gene Symbol: TUBA7L
1 Cross references
29 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSOTSG00005017320
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSOTSG00005035099
Gene Symbol: LOC112228715
3 Cross references
181 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOTSG00005001817
Gene Symbol: TYR
1 Cross references
201 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOTSG00005017828
Gene Symbol: TYR
1 Cross references
194 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSOTSG00005011006
Gene Symbol: TYR
1 Cross references
194 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSOTSG00005024912
Gene Symbol: TH
1 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOTSG00005034719
Gene Symbol: TYK2
3 Cross references
190 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSOTSG00005018870
Gene Symbol: TYK2
1 Cross references
190 Possible Orthologues:

Tyrosine-Protein Kinase Frk-Like

Ensembl ID : ENSOTSG00005013739
Gene Symbol: LOC112214644
2 Cross references
188 Possible Orthologues:

Tyrosine-Protein Kinase Hck-Like

Ensembl ID : ENSOTSG00005004473
Gene Symbol: LOC112215985
2 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).